DAX trends positively before the Christmas holidays - Novo Nordisk with price jump after FDA approval for Wegovy pill - Alphabet with multi-billion acquisition in data infrastructure - Woodward favored after positive analyst comment from Deutsche Bank!
Reading Time: 6 minutes
The DAX is showing a slight increase in early trading on Tuesday. After a generally steady start to trading, the German leading index manages to defend its initial gains by midday and is up by nearly 0.13%: In light of the upcoming Christmas holidays, many investors are understandably holding back on larger commitments. In an otherwise news-light environment, the stock of Novo Nordisk (+7.25%) stands out. The company received approval from the FDA for Wegovy tablets in the USA the previous evening, resulting in significant gains for the pharmaceutical...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
